EDGAR Filing Documents for 0001104659-21-056646

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001104659-21-056646

Filing Date

2021-04-28

Accepted

2021-04-28 17:14:39

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	tm212508d3_defa14a.htm	DEFA14A	18525
2	GRAPHIC	tm212508d3_defa14aimage001.jpg	GRAPHIC	339606
3	GRAPHIC	tm212508d3_defa14aimage002.jpg	GRAPHIC	297500
	Complete submission text file	0001104659-21-056646.txt		897291

Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807

Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300

Osmotica Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000
Type: DEFA14A | Act: 34 | File No.: 001-38709 | Film No.: 21865513
SIC: 2834 Pharmaceutical Preparations